Allergy Therapeutics plc (LON:AGY – Get Free Report) shares dropped 13.7% on Thursday. The stock traded as low as GBX 1.21 and last traded at GBX 1.21. 8,691,818 shares were traded during trading, an increase of 1,548% from the average session volume of 527,447 shares. The stock had previously closed at GBX 1.40.
Allergy Therapeutics Stock Performance
The firm has a fifty day moving average of GBX 3.88 and a 200-day moving average of GBX 7.44. The company has a quick ratio of 1.48, a current ratio of 2.29 and a debt-to-equity ratio of -646.31. The stock has a market capitalization of £76.50 million, a price-to-earnings ratio of -1.25, a PEG ratio of -30.70 and a beta of 0.83.
Allergy Therapeutics Company Profile
See Also
- Five stocks we like better than Allergy Therapeutics
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
